Analysis of Prior Aspirin Treatment on in-Hospital Outcome of Geriatric COVID-19 Infected Patients

Background and Objectives: Aspirin (ASA) is a commonly used antithrombotic drug that has been demonstrated to reduce venous thromboembolism. The aim was to analyze if geriatric COVID-19 patients undergoing a 100 mg/day Aspirin (ASA) treatment prior to hospitalization differ in hospital outcome compa...

Descripción completa

Detalles Bibliográficos
Autores principales: Zekri-Nechar, Khaoula, Barberán, José, Zamorano-León, José J., Durbán, María, Andrés-Castillo, Alcira, Navarro-Cuellar, Carlos, López-Farré, Antonio, López-de-Andrés, Ana, Jiménez-García, Rodrigo, Martínez-Martínez, Carlos H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9694688/
https://www.ncbi.nlm.nih.gov/pubmed/36422187
http://dx.doi.org/10.3390/medicina58111649

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9694688/
https://www.ncbi.nlm.nih.gov/pubmed/36422187
http://dx.doi.org/10.3390/medicina58111649

Ejemplares similares